Newcastle Disease Virus as a Vaccine Vector for SARS-CoV-2

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in more than 16 million infections and more than 600,000 deaths worldwide. There is an urgent need to develop a safe and effective vaccine against SARS-CoV-2. Currently, several strategies are being pursued to...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirvani, Edris, Samal, Siba K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459537/
https://www.ncbi.nlm.nih.gov/pubmed/32751194
http://dx.doi.org/10.3390/pathogens9080619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459537/
https://www.ncbi.nlm.nih.gov/pubmed/32751194
http://dx.doi.org/10.3390/pathogens9080619

Ejemplares similares